Curaleaf Holdings (FRA:2XW) Notes Receivable: €6 Mil (As of Mar. 2026)


FRA:2XW Curaleaf Holdings Inc FRA:2XW
46 GF Score
Price €8.23
GF Value €6.56
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Notes Receivable?

Curaleaf Holdings FRA:2XW +4.25% 46 Notes Receivable is €6 Mil as of Mar. 2026. GuruFocus rates FRA:2XW with a GF Score™ of 46/100 and a GF Value™ of €6.56 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Curaleaf Holdings's Notes Receivable for the quarter that ended in Mar. 2026 was €6 Mil.

Curaleaf Holdings's quarterly Notes Receivable increased from Sep. 2025 (€2.37 Mil) to Dec. 2025 (€3.95 Mil) and increased from Dec. 2025 (€3.95 Mil) to Mar. 2026 (€5.51 Mil).

Curaleaf Holdings's annual Notes Receivable declined from Dec. 2023 (€6.44 Mil) to Dec. 2024 (€0.43 Mil) but then increased from Dec. 2024 (€0.43 Mil) to Dec. 2025 (€3.95 Mil).

Curaleaf Holdings Notes Receivable Related Terms

Curaleaf Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings Notes Receivable Chart

Curaleaf Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.05 0.00 6.44 0.43 3.95

Curaleaf Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 1.86 2.37 3.95 5.51
FRA:2XW
46GF Score
Curaleaf Holdings Inc FRA:2XW
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curaleaf Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €6 Mil mean?
Curaleaf Holdings (FRA:2XW) has a Notes Receivable of €6 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Curaleaf Holdings and its competitors.
Is Curaleaf Holdings' Notes Receivable too high?
Curaleaf Holdings' current Notes Receivable is €6 Mil. Overall, Curaleaf Holdings has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Notes Receivable compare to ZTS?
Curaleaf Holdings' Notes Receivable of €6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Curaleaf Holdings and its competitors. Curaleaf Holdings's current Notes Receivable is €6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (FRA:2XW) is currently considered Modestly Overvalued. The stock's GF Value™ is €6.56, compared to a current price of €8.23 — trading 25.4% above its estimated fair value. The current Notes Receivable is €6 Mil. Curaleaf Holdings' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Curaleaf Holdings (FRA:2XW), the current Notes Receivable is €6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (FRA:2XW) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of €8.23 is trading 25.4% above its estimated GF Value™ of €6.56. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for FRA:2XW:

  • Notes Receivable: €6 Mil
  • GF Value™: €6.56 vs. price of €8.23 (25.4% above fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the FRA:2XW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Other Exchanges CURLD:USACURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
46GF Score

Get the complete analysis for FRA:2XW

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.23
Price
€6.56
GF Value